News | February 27, 2026
Star Health & Allied Insurance rolls out 32 free primary care clinics across 9 states
The initiative, funded entirely under the company’s CSR programme, is expected to reach over a million lives
The initiative, funded entirely under the company’s CSR programme, is expected to reach over a million lives
The program offers selected participants advanced access to Promise Bio’s broad-epiproteomic platform
Expansion at the Oss (NL) site adds capacity and R&D capabilities, supporting the development and manufacturing of ADCs and other novel bioconjugates from First-in-Human to commercialization
The agreement ensures BIOEMTECH customers can consistently obtain Ac-225 for preclinical studies
BioAsia 2026 represents a decisive shift toward execution, scale, and global competitiveness, reflecting the rapid evolution of the life sciences ecosystem
The paper highlights how conditions common across India—including anemia, inherited hemoglobin disorders, and glucose-6-phosphate dehydrogenase (G6PD) deficiency—can significantly distort HbA1c readings
The approved scheme will deliver around 1 million sq ft of state-of-the-art laboratory and research space across a 12-acre site
HYMPAVZI is already approved in the US for patients 12 and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors
The facility is dedicated to breakthrough innovations in laboratory instruments that detect infectious diseases, cancer, and blood disorders
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
